All In MedTech

Device Trial Radar · NCT04192474

Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy

Clinical Investigation to Evaluate the Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy

Last checked: Nov 20, 2026Latest source record: Oct 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

83

Actual

Start

Jul 21, 2020

Primary completion

Apr 7, 2021

Study completion Jun 30, 2021

Sponsor

Lead sponsor
Ambu A/SNot on our public-company list
Sponsor type
Industry
Collaborators
QserveCRO
First posted
Dec 10, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In this study, the new aScope 4 Cysto is used to see if this new single use, flexible cystoscope performs as well as other routinely used flexible cystoscopes. This study will be done in patients who come to the clinic for either a diagnosis of their urethra and bladder or for a small intervention. For an intervention a lesion or tumor is resected, a stent in the ureter is taken out, or an injection in the bladder wall is given. The flexible cystoscope is passed into the urethra and bladder for visual inspection of the bladder and urethra. It will give information on how well the structures of the urinary tract and bladder can be viewed including any abnormalities that are present. If an intervention is performed the aScope 4 Cysto will be used with an endoscopic accessory.

Conditions

  • Cystoscope
  • Lower Urinary Tract Symptoms
  • Bladder Disease

Interventions

  • Flexible cystoscopyDevice

    Treatment with the investigational device: Ambu® aScope™ 4 Cysto

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance of the cystoscopeTime frame: follow up immediately after procedure

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Herlev Hospital

    Herlev, Denmark

  • Erasmus MC

    Rotterdam, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.